Mathews Kusum S, Soh Howard, Shaefi Shahzad, Wang Wei, Bose Sonali, Coca Steven, Gupta Shruti, Hayek Salim S, Srivastava Anand, Brenner Samantha K, Radbel Jared, Green Adam, Sutherland Anne, Leonberg-Yoo Amanda, Shehata Alexandre, Schenck Edward J, Short Samuel A P, Hernán Miguel A, Chan Lili, Leaf David E
Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Crit Care Med. 2021 Jul 1;49(7):1026-1037. doi: 10.1097/CCM.0000000000004938.
Therapies for patients with respiratory failure from coronavirus disease 2019 are urgently needed. Early implementation of prone positioning ventilation improves survival in patients with acute respiratory distress syndrome, but studies examining the effect of proning on survival in patients with coronavirus disease 2019 are lacking. Our objective was to estimate the effect of early proning initiation on survival in patients with coronavirus disease 2019-associated respiratory failure.
Data were derived from the Study of the Treatment and Outcomes in Critically Ill Patients with coronavirus disease 2019, a multicenter cohort study of critically ill adults with coronavirus disease 2019 admitted to 68 U.S. hospitals. Using these data, we emulated a target trial of prone positioning ventilation by categorizing mechanically ventilated hypoxemic (ratio of Pao2 over the corresponding Fio2 ≤ 200 mm Hg) patients as having been initiated on proning or not within 2 days of ICU admission. We fit an inverse probability-weighted Cox model to estimate the mortality hazard ratio for early proning versus no early proning. Patients were followed until death, hospital discharge, or end of follow-up.
ICUs at 68 U.S. sites.
Critically ill adults with laboratory-confirmed coronavirus disease 2019 receiving invasive mechanical ventilation with ratio of Pao2 over the corresponding Fio2 less than or equal to 200 mm Hg.
None.
Among 2,338 eligible patients, 702 (30.0%) were proned within the first 2 days of ICU admission. After inverse probability weighting, baseline and severity of illness characteristics were well-balanced between groups. A total of 1,017 (43.5%) of the 2,338 patients were discharged alive, 1,101 (47.1%) died, and 220 (9.4%) were still hospitalized at last follow-up. Patients proned within the first 2 days of ICU admission had a lower adjusted risk of death compared with nonproned patients (hazard ratio, 0.84; 95% CI, 0.73-0.97).
In-hospital mortality was lower in mechanically ventilated hypoxemic patients with coronavirus disease 2019 treated with early proning compared with patients whose treatment did not include early proning.
迫切需要针对2019冠状病毒病呼吸衰竭患者的治疗方法。早期实施俯卧位通气可提高急性呼吸窘迫综合征患者的生存率,但缺乏关于俯卧位对2019冠状病毒病患者生存率影响的研究。我们的目的是评估早期开始俯卧位通气对2019冠状病毒病相关呼吸衰竭患者生存率的影响。
数据来自对2019冠状病毒病重症患者的治疗与结局研究,这是一项对美国68家医院收治的2019冠状病毒病成年重症患者进行的多中心队列研究。利用这些数据,我们通过将机械通气的低氧血症患者(动脉血氧分压与相应的吸氧浓度之比≤200 mmHg)分类为在重症监护病房(ICU)入院后2天内是否开始进行俯卧位通气,模拟了一项俯卧位通气的目标试验。我们拟合了一个逆概率加权Cox模型,以估计早期俯卧位通气与未早期俯卧位通气相比的死亡风险比。对患者进行随访直至死亡、出院或随访结束。
美国68个地点的ICU。
实验室确诊为2019冠状病毒病且接受有创机械通气、动脉血氧分压与相应的吸氧浓度之比小于或等于200 mmHg的成年重症患者。
无。
在2338例符合条件的患者中,702例(30.0%)在ICU入院后的头2天内接受了俯卧位通气。经过逆概率加权后,两组之间的基线和疾病严重程度特征达到了良好的平衡。2338例患者中共有1017例(43.5%)存活出院,1101例(47.1%)死亡,220例(9.4%)在最后一次随访时仍住院。与未接受俯卧位通气的患者相比,在ICU入院后头2天内接受俯卧位通气的患者经调整后的死亡风险更低(风险比,0.84;95%置信区间,0.73 - 0.97)。
与未进行早期俯卧位通气治疗的患者相比,早期进行俯卧位通气治疗的2019冠状病毒病机械通气低氧血症患者的院内死亡率更低。